Loading viewer...
investor_presentation
Format: PDF investor_presentation
OpSens is a cardiovascular company leveraging proprietary optical technology for coronary artery disease monitoring and aortic valve stenosis applications. The company's core business includes OptoWire for fractional flow reserve measurement and SavvyWire for transcatheter aortic valve replacement, with strategic partnerships in neurology and ventricular assist devices.
OpSens Inc. 2023 Investor Presentation
investor_presentation
44 Pages
investor_presentation
37 Pages
Yapı Kredi
Al Anwar Investments SAOG Right Issue 2025
investor_presentationinvestor_presentation
25 Pages
AL ANWAR INVESTMENTS SAOG
Regeneron Pharmaceuticals 2022 Corporate Investor Presentation
investor_presentationinvestor_presentation
23 Pages
Regeneron Pharmaceuticals, Inc.